Hatton, Catherine F. http://orcid.org/0000-0003-4138-5309
Botting, Rachel A. http://orcid.org/0000-0001-9595-4605
Dueñas, Maria Emilia http://orcid.org/0000-0003-3411-4068
Haq, Iram J. http://orcid.org/0000-0002-5795-0440
Verdon, Bernard http://orcid.org/0000-0002-5804-9419
Thompson, Benjamin J. http://orcid.org/0000-0002-3360-587X
Spegarova, Jarmila Stremenova http://orcid.org/0000-0002-0710-9266
Gothe, Florian http://orcid.org/0000-0003-0421-6610
Stephenson, Emily
Gardner, Aaron I. http://orcid.org/0000-0001-8729-9823
Murphy, Sandra http://orcid.org/0000-0002-1130-9295
Scott, Jonathan
Garnett, James P. http://orcid.org/0000-0002-4767-020X
Carrie, Sean
Powell, Jason http://orcid.org/0000-0002-1199-8406
Khan, C. M. Anjam http://orcid.org/0000-0003-4381-8729
Huang, Lei http://orcid.org/0000-0002-1996-944X
Hussain, Rafiqul
Coxhead, Jonathan http://orcid.org/0000-0002-6128-9560
Davey, Tracey
Simpson, A. John http://orcid.org/0000-0003-4731-7294
Haniffa, Muzlifah http://orcid.org/0000-0002-3927-2084
Hambleton, Sophie http://orcid.org/0000-0001-7954-3267
Brodlie, Malcolm http://orcid.org/0000-0003-4591-8299
Ward, Chris http://orcid.org/0000-0002-6954-9611
Trost, Matthias
Reynolds, Gary
Duncan, Christopher J. A. http://orcid.org/0000-0003-4181-2315
Funding for this research was provided by:
RCUK | Medical Research Council (MR/NO13840/1, MR/M008797/1, MR/NO13840/1)
Medical Research Council SHIELD antimicrobial resistance consortium, NIHR Research Professorship
Wellcome Trust (WT107931/Z/15/Z, 207556/Z/17/Z, 215542/Z/19/Z, 214539/Z/18/Z, 211153/Z/18/Z)
The Lister Institute for Preventive Medicine, Newcastle NIHR Biomedical Research Centre (BRC), Barbour Foundation, UK-Coronavirus Immunology Consortium
Barbour Foundation UK-Coronavirus Immunology Consortium
Article History
Received: 16 February 2021
Accepted: 12 November 2021
First Online: 7 December 2021
Competing interests
: S.H. declares honoraria from CSL Behring and Takeda for teaching and consultancy. M.B. declares being CI on investigator-led research grants from Pfizer and Roche Diagnostics; speaker fees paid to Newcastle University from Novartis, Roche Diagnostics and TEVA; travel expenses to educational meetings from Boehringer Ingelheim and Vertex. The remaining authors declare no competing interests.